Articles

Browse our regulatory articles below or search through our archive.

 


 

  • 5 QUESTIONS & ANSWERS: STRATEGIC REGULATORY PLANNING FOR YOUNG MEDTEC COMPANIES

    Posted on Nov 06, 2012
    An Interview with Arazy Group President & CEO Benjamin Arazy. 2013 will not be an easy year for MedTech. Last year, MedTec investments in the United States declined by 27% compared to 2011 and this trend is expected to continue. Funding from venture capital funds for this industry have been declining due to a back log of medical device companies seeking an "exit" in the next ten years. The main difficulty will be for startups in the early stages of... Continue reading
latest news
  • Aug 8 2018
    REGULATORY UPDATE - ORASURE TECHNOLOGIES

    Nepal: OraSure Technologies' OraQuick HIV Self-Test was approved for sale with LICENSALE.COM®....

    Read More
  • Aug 2 2018
    JOB POSTING: CLIENT MANAGER

    Arazy Group Consultants Inc. is currently seeking qualified applicants for the position of Client Manager. ...

    Read More
  • Jul 17 2018
    REGULATORY UPDATE - ORASURE TECHNOLOGIES

    Mozambique: OraSure Technologies' HIVST test kit was approved for sale with LICENSALE.COM®....

    Read More
  • Jul 16 2018
    REGULATORY UPDATE - DR. KORMAN LABORATORIES

    Colombia: Dr. Korman Laboratories' Dermal Fillers were approved for sale with LICENSALE.COM®....

    Read More
  • Jul 12 2018
    REGULATORY UPDATE - ORASURE TECHNOLOGIES

    Namibia: OraSure Technologies' OraQuick HIV Self-Test was approved for sale with LICENSALE.COM®....

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP